http://orcid.org/0000-0002-1610-6024
Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alexander Muik, Isil Altintas, Friederike Gieseke, Kristina B Schoedel, Saskia M Burm, Aras Toker, Theodora W. Salcedo, Dennis Verzijl, David Eisel, Christian Grunwitz, Lena M Kranz, Mathias Vormehr, David P.E. Satijn, Mustafa Diken, Sebastian Kreiter, Kate Sasser, Tahamtan Ahmadi, Özlem Türeci, Esther C.W. Breij, Maria Jure-Kunkel & Ugur Sahin. (2022) An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation. OncoImmunology 11:1.
Read now
Read now
Shi-Long Zhang, Bing Han, Yu-Qin Mao, Zheng-Yan Zhang, Zhan-Ming Li, Chao-Yue Kong, You Wu, Guo-Qiang Chen & Li-Shun Wang. (2022) Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice. Gut Microbes 14:1.
Read now
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Read now
Articles from other publishers (35)
Shaoxian Wu, Hao Huang, Runzi Sun, David Shihong Gao, Fan Ye, Jianing Huang, Ella Li, Andrew Ni, Kevin GuoKai Lu, Kong Chen, Jingting Jiang, Penelope A. Morel, Ziyang Zhong & Binfeng Lu. (2023) Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer Research Communications 3:8, pages 1460-1472.
Crossref
Crossref
Maria Vasileiou, Savvas Papageorgiou & Nam P. Nguyen. (2023) Current Advancements and Future Perspectives of Immunotherapy in Breast Cancer Treatment. Immuno 3:2, pages 195-216.
Crossref
Crossref
Zoriamin Rivera, Carlos Escutia, Mary Beth Madonna & Kajal H. Gupta. (2023) Biological Insight and Recent Advancement in the Treatment of Neuroblastoma. International Journal of Molecular Sciences 24:10, pages 8470.
Crossref
Crossref
Daria Vinokurova & Lionel Apetoh. (2023) The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy. Biomolecules 13:4, pages 670.
Crossref
Crossref
Jing Wang, Yanan Wang, Hanyu Pan, Lin Zhao, Xinyi Yang, Zhiming Liang, Xiaoting Shen, Jing Zhang, Jinlong Yang, Yuqi Zhu, Jingna Xun, Yue Liang, Qinru Lin, Huitong Liang, Min Li & Huanzhang Zhu. (2023) Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. International Journal of Molecular Sciences 24:6, pages 5424.
Crossref
Crossref
Anna Lyubetskaya, Brian Rabe, Andrew Fisher, Anne Lewin, Isaac Neuhaus, Constance Brett, Todd Brett, Ethel Pereira, Ryan Golhar, Sami Kebede, Alba Font-Tello, Kathy Mosure, Nicholas Van Wittenberghe, Konstantinos J. Mavrakis, Kenzie MacIsaac, Benjamin J. Chen & Eugene Drokhlyansky. (2022) Assessment of spatial transcriptomics for oncology discovery. Cell Reports Methods 2:11, pages 100340.
Crossref
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) Checkpoint inhibitor/interleukin‐based combination therapy of cancer. Cancer Medicine 11:15, pages 2934-2943.
Crossref
Crossref
Tristan Rupp, Laurie Genest, David Babin, Christophe Legrand, Marion Hunault, Guillaume Froget & Vincent Castagné. (2022) Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response. Translational Oncology 20, pages 101405.
Crossref
Crossref
Colleen L. Mayberry, Natalie A. Logan, John J. Wilson & Chih-Hao Chang. (2022) Providing a Helping Hand: Metabolic Regulation of T Follicular Helper Cells and Their Association With Disease. Frontiers in Immunology 13.
Crossref
Crossref
Patrick G. Holder, Shion A. Lim, Christine S. Huang, Preeti Sharma, Yavuz S. Dagdas, Beyza Bulutoglu & Jonathan T. Sockolosky. (2022) Engineering interferons and interleukins for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114112.
Crossref
Crossref
Nader El-Sayes, Alyssa Vito, Omar Salem, Samuel Tekeste Workenhe, Yonghong Wan & Karen Mossman. (2022) A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner. International Journal of Molecular Sciences 23:3, pages 1754.
Crossref
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) (Im)maturity in Tumor Ecosystem. Frontiers in Oncology 11.
Crossref
Crossref
Alexandra A. Wolfarth, Swati Dhar, Jack B. Goon, Ugonna I. Ezeanya, Sara Ferrando-Martínez & Byung Ha Lee. (2022) Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy. Immune Network 22:1.
Crossref
Crossref
Ying Li, Yanni Cong, Mingming Jia, Qianqian He, Haiqing Zhong, Yun Zhao, Hang Li, Meining Yan, Jia You, Jia Liu, Lieping Chen, Haiying Hang & Shengdian Wang. (2021) Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy. Nature Communications 12:1.
Crossref
Crossref
Hongchuan Liu, Rui Wang, Duopeng An, Hui Liu, Fan Ye, Baoxian Li, Jing Zhang, Peixiang Liu, Xuyao Zhang, Sheng Yao, Ziyang Zhong, Hui Feng & Meiqing Feng. (2021) An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade. International Immunopharmacology 101, pages 108307.
Crossref
Crossref
Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Adrián Arnaiz-Leché & Sergio Roa. (2021) The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas. Cancers 13:18, pages 4683.
Crossref
Crossref
Xuqing Zhang, Mengyao Luo, Shamael R. Dastagir, Mellissa Nixon, Annie Khamhoung, Andrea Schmidt, Albert Lee, Naren Subbiah, Douglas C. McLaughlin, Christopher L. Moore, Mary Gribble, Nicholas Bayhi, Viral Amin, Ryan Pepi, Sneha Pawar, Timothy J. Lyford, Vikram Soman, Jennifer Mellen, Christopher L. Carpenter, Laurence A. Turka, Thomas J. Wickham & Tiffany F. Chen. (2021) Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic. Nature Communications 12:1.
Crossref
Crossref
Lin Dong, Ying He, Yejin Cao, Yuexin Wang, Anna Jia, Yufei Wang, Qiuli Yang, Wanjie Li, Yujing Bi & Guangwei Liu. (2020) Functional differentiation and regulation of follicular T helper cells in inflammation and autoimmunity. Immunology 163:1, pages 19-32.
Crossref
Crossref
Léa Paolini, Antonin Saldmann & Eric Tartour. (2021) Lymphocytes T-CD8 et immunothérapie anti-tumorale : rôle et Ciblage thérapeutique. Bulletin de l'Académie Nationale de Médecine 205:4, pages 354-363.
Crossref
Crossref
Julia Peña-Asensio, Henar Calvo, Miguel Torralba, Joaquín Miquel, Eduardo Sanz-de-Villalobos & Juan-Ramón Larrubia. (2021) Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C. Cells 10:3, pages 538.
Crossref
Crossref
Zhengyang Hu, Guoshu Bi, Qihai Sui, Yunyi Bian, Yajing Du, Jiaqi Liang, Ming Li, Cheng Zhan, Zongwu Lin & Qun Wang. (2020) Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma. International Immunopharmacology 88, pages 106910.
Crossref
Crossref
Shanling Shen, Gail Sckisel, Anupama Sahoo, Almin Lalani, Doug Den Otter, Josh Pearson, Jason DeVoss, Jay Cheng, Stephanie C. Casey, Ryan Case, Melissa Yang, Ray Low, Mark Daris, Bin Fan, Neeraj J. Agrawal & Khaled Ali. (2020) Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. Frontiers in Immunology 11.
Crossref
Crossref
Lena Gaissmaier & Petros Christopoulos. (2020) Immune Modulation in Lung Cancer: Current Concepts and Future Strategies. Respiration 99:11, pages 903-929.
Crossref
Crossref
Raki Sudan. 2020. Systems and Synthetic Immunology. Systems and Synthetic Immunology
255
269
.
Jiaojiao Xu, Sheng Yu, Xiaodong Wang, Yuyi Qian, Weishu Wu, Sihang Zhang, Binbin Zheng, Guoguang Wei, Shuai Gao, Zhonglian Cao, Wei Fu, Zeyu Xiao & Wei Lu. (2019) High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy. ACS Nano 13:9, pages 10242-10260.
Crossref
Crossref
E Fiegle, D Doleschel, S Koletnik, A Rix, R Weiskirchen, E Borkham-Kamphorst, F Kiessling & W Lederle. (2019) Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer. Neoplasia 21:9, pages 932-944.
Crossref
Crossref
Vylyny Chat, Robert Ferguson & Tomas Kirchhoff. (2019) Germline genetic host factors as predictive biomarkers in immuno-oncology. Immuno-Oncology and Technology 2, pages 14-21.
Crossref
Crossref
Junming Peng, Liefu Ye, Tao Li, Qingguo Zhu, Jinan Guo, Kefeng Xiao & Yongbao Wei. (2019) Irradiated Bladder Cancer Cells Expressing both GM-CSF and IL-21 versus Either GM-CSF or IL-21 Alone as Tumor Vaccine in a Mouse Xenograft Model. BioMed Research International 2019, pages 1-8.
Crossref
Crossref
Vylyny Chat, Robert Ferguson, Danny Simpson, Esther Kazlow, Rebecca Lax, Una Moran, Anna Pavlick, Dennie Frederick, Genevieve Boland, Ryan Sullivan, Antoni Ribas, Keith Flaherty, Iman Osman, Jeffrey Weber & Tomas Kirchhoff. (2019) Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition. Cancer Immunology, Immunotherapy 68:6, pages 897-905.
Crossref
Crossref
Mitra Shourian, Jean-Christophe Beltra, Benoîte Bourdin & Hélène Decaluwe. (2019) Common gamma chain cytokines and CD8 T cells in cancer. Seminars in Immunology 42, pages 101307.
Crossref
Crossref
Ge Li, Chunmei Hou, Shuaijie Dou, Jiacheng Zhang, Yanling Zhang, Yiqiong Liu, Zhiding Wang, He Xiao, Renxi Wang, Guojiang Chen, Yan Li, Jiannan Feng, Beifen Shen & Gencheng Han. (2019) Monoclonal antibody against human Tim-3 enhances antiviral immune response. Scandinavian Journal of Immunology 89:2, pages e12738.
Crossref
Crossref
Aras Toker & Pamela S. Ohashi. 2019.
193
261
.
Kyuri Lee, Minjeong Kim, Yunmi Seo & Hyukjin Lee. (2018) Development of mRNA vaccines and their prophylactic and therapeutic applications. Nano Research 11:10, pages 5173-5192.
Crossref
Crossref
Antigoni Poultsidi, Yiannis Dimopoulos, Ting-Fang He, Triantafyllos Chavakis, Emmanouil Saloustros, Peter P. Lee & Constantinos Petrovas. (2018) Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells?. Frontiers in Immunology 9.
Crossref
Crossref
Lan Dai, Linyan He, Zhaoyue Wang, Xia Bai, Yang He, Lijuan Cao, Mingqing Zhu & Changgeng Ruan. (2018) Altered circulating T follicular helper cells in patients with chronic immune thrombocytopenia. Experimental and Therapeutic Medicine.
Crossref
Crossref